Also trades as: 0IGA.L (LSE) · $vol 0M
EBS NYSE
Emergent BioSolutions Inc.
1W: -0.3%
1M: -6.6%
3M: -13.3%
YTD: -49.3%
1Y: -34.4%
3Y: +185.6%
5Y: -87.4%
$6.67
+0.33 (+5.21%)
After Hours: $6.64 (-0.03, -0.37%)
Weekly Expected Move ±10.7%
$5
$6
$6
$7
$8
Credit Risk of going bust: higher than 91% of companies Debt: 64.2% of company value Bonds: $63.5M held by 75 funds, 397 bp over Treasuries → details ▾
Of US companies ranked in the riskiest tenth, about 1 in 20 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $1.11 (down 82%), Emergent BioSolutions Inc. would be worth roughly what it owes.
Total debt $581.8M against a stock market value of $325.1M.
Distance to default 1.48 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $290.9M (short-term plus half of long-term), stock volatility 81.0%; Altman Z 0.83. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
If the stock fell to about $1.11 (down 82%), Emergent BioSolutions Inc. would be worth roughly what it owes.
Total debt $581.8M against a stock market value of $325.1M.
Distance to default 1.48 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $290.9M (short-term plus half of long-term), stock volatility 81.0%; Altman Z 0.83. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$770M
Revenue
-9.6% YoY
$-177M
Net Income
-226.7% YoY
$86M
Free Cash Flow
-44.6% YoY
58.6%
Gross Margin
-53.4%
Op. Margin
-76.9%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-40.3%
ROA-14.0%
ROIC-5.5%
Valuation
P/E-1.9
P/B1.0
EV/EBITDA-8745.1
Leverage
Debt/Equity1.70
Current Ratio5.42
Interest Cov.-1.9x
Quality Scores
Piotroski F5/9
Altman Z0.91
Beneish M-2.91